Co-Authors
This is a "connection" page, showing publications co-authored by Thomas Benfield and Marie Helleberg.
Connection Strength
0.528
-
Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study. Clin Infect Dis. 2021 12 06; 73(11):2031-2036.
Score: 0.246
-
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial. Acta Anaesthesiol Scand. 2021 11; 65(10):1421-1430.
Score: 0.061
-
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2021 Jul; 65(6):834-845.
Score: 0.058
-
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysis. Acta Anaesthesiol Scand. 2021 05; 65(5):702-710.
Score: 0.058
-
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial-Protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2020 10; 64(9):1365-1375.
Score: 0.056
-
Whole Exome Sequencing of HIV-1 long-term non-progressors identifies rare variants in genes encoding innate immune sensors and signaling molecules. Sci Rep. 2018 10 15; 8(1):15253.
Score: 0.049